A study published in the New England Journal of Medicine (NEJM) on April 26, 2015 states that the incidence of Neonatal Abstinence Syndrome (NAS) in the USA is on the rise.
Neonatal Abstinence Syndrome (NAS) is defined as a set of problems occurring in a newborn exposed to addictive opiate drugs during gestation. When a pregnant woman takes opioid drugs such as heroin, codeine, oxycodone, etc., the drugs pass through the placenta and enter the fetus, thereby making the fetus addicted to the drug/s as well. In other words, NAS is the term used for drug-withdrawal symptoms in a newborn.
Newborns with NAS have symptoms like irritability, poor sucking reflex, highly tense muscles, inability to control some functions that the body does naturally/automatically (For example, digestion, blood pressure control etc.), weight gain issues, etc.
The study in the NEJM was designed to look into the rate of NAS occurrence, the rate of hospitalizations in Neonatal Intensive Care Units (NICUs), the duration of hospital stays, and changes in infant and maternal clinical characteristics from 2003 through 2014. Data from a total of 299 NICUs were analyzed for this investigation. The results show that:
The authors conclude “From 2004 through 2013, the neonatal abstinence syndrome was responsible for a substantial and growing portion of resources dedicated to critically ill neonates in NICUs nationwide.”
Calling this a dramatic problem, the lead author of the NEJM research article, Dr. Alan Spitzer, says to Forbes magazine “Increasingly these are not illicit street drugs, but prescription drugs that mothers are using that they’re getting from a variety of sources, some from obstetricians, some from pain clinics now that have appeared all over the place.”
“Having discussed this with many of our physicians as well as some parents I think they’ve been led to believe that if they have aches and pains, and they take these medications, it’s perfectly safe. And it’s not.”
With the backdrop of increased deaths associated with use of narcotic painkillers and substantial hospitalization charges for the NICU (one estimate puts the cost at $40,000 per infant), combined with lack of data on the long-term effects of gestational opioid exposure on the brain, overuse of prescription painkillers is a problem that needs to be dealt with in an expeditious manner.
Primary Reference:
Tolia, V., Patrick, S., Bennett, M., Murthy, K., Sousa, J., Smith, B., . . . Spitzer, A. (2015). Increasing Incidence of the Neonatal Abstinence Syndrome in U.S. Neonatal ICUs. New England Journal of Medicine.
http://www.nejm.org/doi/full/10.1056/NEJMsa1500439#t=article
Additional References:
Neonatal abstinence syndrome: MedlinePlus Medical Encyclopedia. (n.d.). Retrieved April 30, 2015, from http://www.nlm.nih.gov/medlineplus/ency/article/007313.htm
Prescription Drug Abuse. (n.d.). Retrieved April 30, 2015, from http://www.drugabuse.gov/publications/research-reports/prescription-drugs/opioids/what-are-opioids
Prescription Pain Pill Overuse Is Leading To Thousands Of Hospitalized Newborns. (n.d.). Retrieved April 30, 2015, from http://www.forbes.com/sites/matthewherper/2015/04/26/the-pain-pill-epidemic-is-hurting-newborn-babies/
The Innocent Victims. (n.d.). Retrieved April 30, 2015, from http://nationalrxdrugabusesummit.org/2012/10/the-innocent-victims/
and connect with fellow professionals
At DoveMed, our utmost priority is your well-being. We are an online medical resource dedicated to providing you with accurate and up-to-date information on a wide range of medical topics. But we're more than just an information hub - we genuinely care about your health journey. That's why we offer a variety of products tailored for both healthcare consumers and professionals, because we believe in empowering everyone involved in the care process.
Our mission is to create a user-friendly healthcare technology portal that helps you make better decisions about your overall health and well-being. We understand that navigating the complexities of healthcare can be overwhelming, so we strive to be a reliable and compassionate companion on your path to wellness.
As an impartial and trusted online resource, we connect healthcare seekers, physicians, and hospitals in a marketplace that promotes a higher quality, easy-to-use healthcare experience. You can trust that our content is unbiased and impartial, as it is trusted by physicians, researchers, and university professors around the globe. Importantly, we are not influenced or owned by any pharmaceutical, medical, or media companies. At DoveMed, we are a group of passionate individuals who deeply care about improving health and wellness for people everywhere. Your well-being is at the heart of everything we do.
0 Comments
Please log in to post a comment.